Country - Germany
Summary - Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A (8) Sgb V For The Active Ingredient Perindopril + Amlodipine, Atc C09Bb04, For The Period April 1, 2021 - March 31, 2023
Deadline - login to view
MT reference number - 64217608
Product classification - Pharmaceutical products
Address - Germany
Contact details - 565656565
Tender notice no. - 76454545
MT Ref Id - 64217608
Document Type - Tender Notices
Description - ยง 130a paragraph 8 SGB V enables the health insurance companies and pharmaceutical companies to conclude framework discount agreements for the drugs to be supplied at the expense of the statutory health insurance companies. With regard to the releva nt legal regulations for the award of public contracts, a regular process of active ingredient-related, formal award procedures takes place according to the regulations of the 4th part of the GWB by the DAK-Gesundheit. For pharmaceuticals to be specified by the bidder in Annex 2 to the contract for the above-mentioned active ingredient (perindopril + amlodipine, ATC C09BB04), DAK-Gesundheit intends to conclude drug discount agreements with as man
Mt Ref Id - 64217608
Deadline - Nov 30, -0001
Similar Tenders :
Healthcare and Medicine